FDA approvals

Podcast
The Top Line
Podcast

Breaking down the 55 new drug approvals of 2024

This week on “The Top Line,” we dive into 2024's FDA drug approvals, highlighting some potential blockbusters and shifts from previous years' lists.
FDA

FDA looks to clarify follow-up testing mandate for speedy nods

Jan 6, 2025 3:36pm
Bristol Myers Squibb

FDA approves BMS' subcutaneous Opdivo with some limitations

Jan 2, 2025 9:15am
topic report
FDA

2024 approvals: Biopharma delivered 55 new drugs, biologics

Jan 2, 2025 3:00am
Vertex

Vertex wins FDA nod for once-daily cystic fibrosis triplet

Dec 23, 2024 10:58am
Asia

Merck's GLP-1 play; Astellas' AAV deal—Fierce Pharma Asia

Dec 20, 2024 8:51am